Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TRB Pharma is a prominent Argentine pharmaceutical company that specializes in the development, production, and commercialization of ethical medications, with a strong focus on chronic degenerative diseases. The company is particularly recognized for its leadership in the rheumatology and traumatology sectors, offering flagship products like Artrodar (diacerein) for the treatment of osteoarthritis. Operating from its headquarters in Buenos Aires and a modern manufacturing plant in Pilar, TRB Pharma adheres to international Good Manufacturing Practice (GMP) standards. Its portfolio also extends into neurology, ophthalmology, and gynecology, serving both the domestic Argentine market and various international territories. Through a combination of internal research and strategic licensing, TRB Pharma continues to provide high-quality therapeutic solutions to healthcare professionals and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TRB Argentina.